Infectious Diseases doc with interests in multi-drug resistant Gram-negative bacteria, and transplant, hem/onc, and burn patients. Opinions are my own.

Joined February 2014
David van Duin retweeted
A behind the scenes look at Tuesday’s congressional hearing on #antimicrobialresistance. Take action on the PASTEUR Act. Your voice will push Congress to create programs to help fight against AMR: idsociety.quorum.us/campaign… @GOPHELP @HELPCmteDems @hboucher3
2
1
13
4,197
David van Duin retweeted
Whatever area of focus, whatever stage in your career, you belong here. Join your colleagues Oct. 11-15 in Boston for #IDWeek2023, the premier meeting for infectious diseases professionals. Register: idweek.org/registration
5
11
2,752
David van Duin retweeted
“Resistance of Acinetobacter baumannii to the recently available cefiderocol is concerning. Sulbactam/durlobactam is a promising option for MDR A. baumannii” Read the article by Tiseo et al: doi.org/10.1093/jacamr/dlad0… @OUPMedicine @OxfordJournals #JACNews
10
25
2,616
David van Duin retweeted
Kakooza et al. report high prevalence of resistance to ciprofloxacin, tetracycline and benzylpenicillin, and emerging resistance determinants for azithromycin, in gonococcal isolates from African countries: doi.org/10.1093/jac/dkad193 @OUPMedicine @OxfordJournals #JACNews
1
1
1
733
David van Duin retweeted
In 2019, an estimated 1.27 million deaths worldwide were directly caused by AMR, and AMR played a part in nearly 5 million deaths. US healthcare costs linked to infections from six of the biggest AMR threats total more than $4.6 billion annually,  with $1.9 billion of these costs borne by Medicare, says @hboucher3 to @GOPHELP and @HELPCmteDems.
1
16
3
30
11,428
David van Duin retweeted
The deadline is fast approaching to submit your team for IDBugBowl, the Jeopardy-style quiz game you know and love. Get your team together and submit your application by July 28: bit.ly/44wmRIo
5
14
4,522
ID BOARD REVIEW 45 YO M from Vietnam moved to the US 20 yrs ago s/p kidney Tx on tacrolimus & prednisone, c/o sudden headache & neck stiffness. LP done & CSF has 2000 WBC’s/mm3 (70% neutrophils), glucose of 10 mg/dl & gram stain has GNB’s. CSF Cx + for E.coli. Empiric Rx is:
18%Cefepime
4%Pipracillin/tazobactam
62%Ceftriaxone + Ivermectin
16%ceftriaxone+vanc+amp
202 votes • Final results
3
3
1
7
3,631
Here is a brief twetorial on test taking strategies and how to approach a multiple choice question. New to posting twetorials & twitter threads, so would love feedback from Twitter gurus @PaulSaxMD @CarlosdelRio7 @davidvanduin @IDSAInfo
Test Taking Strategies for the Boards & In training exam (ITE). How to take multiple choice tests? Here's a twetorial on test-taking and preparing for boards and ITE's. #TestTaking #StudyTips @SuperBugDoc @IDSAMedEdCOP @swinndong @PaulSaxMD
1
2
8
1,766
David van Duin retweeted
We are looking for PhD candidates🎓 to join our ERC Grant about the spread of antibiotic resistance. Dive into structural biology, biochemistry and microbiology in University of Geneva🇨🇭with cutting edge equipment for cryo-EM/ET and a beautifully place to work! please RT🔁
22
311
6
565
136,221
Long ago, the field of ID could have carved out paid niches in the interpretation of cultures, susceptibilities, etc. (like other specialties do). However, none of that happened and today the specialty can't attract sufficient fellows because other fields are more lucrative.
Because, as @ACasadevall1 taught me years ago, decades ago the ID community failed to work with government and regulators to protect the special expertise unique to ID training. Other specialties were much more proactive in carving out their controlled expertise.
4
8
1
43
47,610
Nice work by Dylan Brown (starting Med school at ⁦@HofstraU⁩ in fall👍👍): Socioeconomic disparities in the prevalence of multidrug resistance in Enterobacterales | Infection Control & Hospital Epidemiology | Cambridge Core cambridge.org/core/journals/…
6
826
David van Duin retweeted
We’re pleased to share our latest impact metrics: JAC-AMR was recently awarded a CiteScore™ (Scopus) of 3.8 & our first Impact Factor (Journal Citation Reports™) of 3.4 Thanks to all our authors, reviewers & Editors! academic.oup.com/jacamr/page… @BSACandJAC @davidvanduin
1
11
2
31
4,579
WHO Global research agenda for antimicrobial resistance in human health who.int/publications/m/item/…
2
5
1,158
This study looks to be quite well done; the authors say that “the results are not generalizable to patients who are immunocompromised”, in whom this can be a devastating, life-threatening infection. I have not had trouble giving four doses of ivermectin.
1
2
11
1,567
Important One Health perspective on #antimicrobialresistance @SidThakur_AMR
1/5 Veterinary #AntimicrobialStewardship is key to the One Health agenda This educational resource review informs vets about available education resources to facilitate excellence in antimicrobial prescribing & #AMR doi.org/10.1093/jacamr/dlad0… @bhogal_pathogen @Ramans2021 #JACAMRNews
1
3
1,040